Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
IN |
|
H
|
H&K AG
PAR:MLHK
|
DE |
|
R E A Holdings PLC
LSE:RE
|
UK |
|
I
|
IcapitalBiz Bhd
KLSE:ICAP
|
MY |
|
G
|
Greatland Resources Ltd
SWB:U0Y
|
AU |
|
M
|
Magis SpA
MIL:MGS
|
IT |
|
D
|
Dialog Group Bhd
KLSE:DIALOG
|
MY |
|
abrdn European Logistics Income PLC
LSE:ASLI
|
UK |
|
P
|
Panther Securities P L C
LSE:PNS
|
UK |
|
Land Securities Group PLC
LSE:LAND
|
UK |
Wall Street
Price Targets
SUNPHARMA Price Targets Summary
Sun Pharmaceutical Industries Ltd
According to Wall Street analysts, the average 1-year price target for
SUNPHARMA
is 2 003.4 INR
with a low forecast of 1 565.5 INR and a high forecast of 2 511.6 INR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is SUNPHARMA's stock price target?
Price Target
2 003.4
INR
According to Wall Street analysts, the average 1-year price target for
SUNPHARMA
is 2 003.4 INR
with a low forecast of 1 565.5 INR and a high forecast of 2 511.6 INR.
What is Sun Pharmaceutical Industries Ltd's Revenue forecast?
Projected CAGR
11%
For the last 13 years the
compound annual growth rate for
Sun Pharmaceutical Industries Ltd's revenue is
16%.
The projected
CAGR
for the next 3 years is
11%.
What is Sun Pharmaceutical Industries Ltd's Operating Income forecast?
Projected CAGR
14%
For the last 13 years the
compound annual growth rate for
Sun Pharmaceutical Industries Ltd's operating income is
12%.
The projected
CAGR
for the next 3 years is
14%.
What is Sun Pharmaceutical Industries Ltd's Net Income forecast?
Projected CAGR
13%
For the last 13 years the
compound annual growth rate for
Sun Pharmaceutical Industries Ltd's net income is
11%.
The projected
CAGR
for the next 3 years is
13%.
